IT1309584B1 - Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso. - Google Patents

Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Info

Publication number
IT1309584B1
IT1309584B1 IT1999MI000396A ITMI990396A IT1309584B1 IT 1309584 B1 IT1309584 B1 IT 1309584B1 IT 1999MI000396 A IT1999MI000396 A IT 1999MI000396A IT MI990396 A ITMI990396 A IT MI990396A IT 1309584 B1 IT1309584 B1 IT 1309584B1
Authority
IT
Italy
Prior art keywords
mage
mhc
class
presented
peptides derived
Prior art date
Application number
IT1999MI000396A
Other languages
English (en)
Italian (it)
Inventor
Maria Pia Protti
Paolo Dellabona
Original Assignee
San Raffaele Centro Fond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Raffaele Centro Fond filed Critical San Raffaele Centro Fond
Priority to IT1999MI000396A priority Critical patent/IT1309584B1/it
Priority to AU29134/00A priority patent/AU2913400A/en
Priority to CA002364002A priority patent/CA2364002A1/fr
Priority to PCT/EP2000/001458 priority patent/WO2000052045A2/fr
Priority to JP2000602269A priority patent/JP2002538166A/ja
Priority to EP00907601A priority patent/EP1161443A2/fr
Publication of ITMI990396A1 publication Critical patent/ITMI990396A1/it
Application granted granted Critical
Publication of IT1309584B1 publication Critical patent/IT1309584B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT1999MI000396A 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso. IT1309584B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
AU29134/00A AU2913400A (en) 1999-02-26 2000-02-23 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
CA002364002A CA2364002A1 (fr) 1999-02-26 2000-02-23 Peptides immunogenes derives de mage-3 presentes par le complexe majeur d'histocompatibilte (mch) de categorie ii et utilisations associees
PCT/EP2000/001458 WO2000052045A2 (fr) 1999-02-26 2000-02-23 Peptides immunogenes derives de mage-3 presentes par le complexe majeur d'histocompatibilte (mch) de categorie ii et utilisations associees
JP2000602269A JP2002538166A (ja) 1999-02-26 2000-02-23 Ｍｈｃクラスｉｉによって提示されるｍａｇｅ−３由来免疫原性ペプチドおよびその使用
EP00907601A EP1161443A2 (fr) 1999-02-26 2000-02-23 Peptides immunogenes derives de mage-3 presentes par le complexe majeur d'histocompatibilte (mch) de categorie ii et utilisations associees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Publications (2)

Publication Number Publication Date
ITMI990396A1 ITMI990396A1 (it) 2000-08-26
IT1309584B1 true IT1309584B1 (it) 2002-01-24

Family

ID=11382063

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Country Status (6)

Country Link
EP (1) EP1161443A2 (fr)
JP (1) JP2002538166A (fr)
AU (1) AU2913400A (fr)
CA (1) CA2364002A1 (fr)
IT (1) IT1309584B1 (fr)
WO (1) WO2000052045A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074847A2 (fr) * 2000-03-30 2001-10-11 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Epitope de lymphocyte t de mage-12 et acides nucleiques, vecteurs et cellules correspondants, compositions et procedes induisant une reaction immunitaire a un cancer
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
AU2002322009A1 (en) 2001-05-18 2002-12-03 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US7049413B2 (en) 2001-05-18 2006-05-23 Ludwig Institute For Cancer Research MAGE-A3 peptides presented by HLA class II molecules
FR2837837B1 (fr) * 2002-03-28 2006-09-29 Roussy Inst Gustave Epitopes peptidiques communs a des antigenes d'une meme famille multigenique
EP1715343B1 (fr) * 2005-04-20 2009-12-09 F. Hoffmann-La Roche Ag Méthode d'identification des épitopes en rapport avec l'immunogénicité des produits bio-pharmaceutiques
WO2008053573A1 (fr) * 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
JP6313478B2 (ja) * 2014-05-30 2018-04-18 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｍａｇｅ−ａ３ペプチド標的アプタマー及びその使用
GB201804468D0 (en) * 2018-03-21 2018-05-02 Valo Therapeutics Oy PeptiCRAd Cancer Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
NZ263050A (en) * 1993-03-05 1997-11-24 Cytel Corp Compositions of immunogenic peptides with hla-a2.1 binding motifs
CA2278189A1 (fr) * 1997-01-31 1998-08-06 Epimmune, Inc. Cellules a peptides ou a antigenes charges de peptides
CN1268738C (zh) * 1997-07-15 2006-08-09 宝生物工程株式会社 细胞毒性t淋巴细胞
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
CA2323632A1 (fr) * 1998-03-13 1999-09-16 Epimmune Inc. Peptides de liaison de hla et leurs applications

Also Published As

Publication number Publication date
WO2000052045A2 (fr) 2000-09-08
EP1161443A2 (fr) 2001-12-12
JP2002538166A (ja) 2002-11-12
ITMI990396A1 (it) 2000-08-26
AU2913400A (en) 2000-09-21
WO2000052045A3 (fr) 2001-01-04
CA2364002A1 (fr) 2000-09-08

Similar Documents

Publication Publication Date Title
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
DE60045324D1 (de) Impfstoffzusammensetzung
NO20014325D0 (no) Vaksine
NO2012006I1 (no) Telaprevir og enhver terapeutisk ekvivalent form derav som er beskyttet av basispatentet, slik som farmasøytisk akseptable salter og/eller solvater avtelaprevir eller solvater av slike salter
DZ2462A1 (fr) Vaccin antigrippal.
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DZ3219A1 (fr) Vaccin
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
AU2273701A (en) Hla class i a2 tumor associated antigen peptides and vaccine compositions
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
DK1356822T3 (da) Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener
IT1309584B1 (it) Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
FR2798291B1 (fr) Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
IT1313655B1 (it) Composizione di fibra di vetro.
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
ITBZ20010003U1 (it) Dispositivo per la protezione di edifici da piene.
NO20021866D0 (no) Ciclesonid-inneholdende vandig farmasöytisk blanding
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
IT1318401B1 (it) Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono.
IS2797B (is) Bóluefni gegn ISA-veiru
IT1314259B1 (it) Procedimento per la preparazione di eteri derivati da acidiidrossibenzoici.
IT1318623B1 (it) Procedimento per la preparazione di derivati dipeptidici.
DE60143020D1 (de) 9-alkylamino-1-nitroacridin-derivate
IT1318396B1 (it) Procedimento per la preparazione di carbammati aromatici da compostinitroaromatici.